Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections
Antimicrobial Agents and Chemotherapy · 2025-10 · 69 (10)
DOI: 10.1128/aac.01060-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025-10. Verfasst von Adrianna M Turner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australi…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Gram-Positive Bacterial Infections, Drug Resistance, Multiple, Bacterial, Enterococcus faecalis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Health and Medical Research Council, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Difficult-to-treat (DTR) enterococcal infections, particularly those caused by multidrug-resistant Enterococcus faecium and Enterococcus faecalis , pose significant clinical challenges due to limited treatment options and high rates of treatment failure, compounded by a paucity of new antimicrobial agents in the development pipeline. Despite advances in understanding resistance mechanisms and in vitro synergistic antibiotic combinations, robust clinical data to guide therapy for severe or DTR enterococcal infections remain limited. This review synthesizes available evidence to inform optimal management strategies, including drug selection and dosing, while highlighting areas needing further research. Given the ongoing threat posed by multidrug-resistant enterococci, we emphasize the importance of gathering robust clinical data to guide best practices for managing these difficult-to-treat infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
- Microbiology Department, Royal Melbourne Hospital, Melbourne, Australia.
- Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.
- Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
- Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
- Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Australia.
ORCID-Profile: Paul Kinsella, William R Miller, Truc T Tran, Benjamin P Howden, Cesar A Arias
Förderung
- NIAID NIH HHS
- National Health and Medical Research Council
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Turner, A. M., Kinsella, P., Miller, W. R., Carter, G. P., Tran, T. T., Howden, B. P., & Arias, C. A. (2025). Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections. Antimicrobial Agents and Chemotherapy, 69(10). https://doi.org/10.1128/aac.01060-24
Vancouver
Turner AM, Kinsella P, Miller WR, Carter GP, Tran TT, Howden BP, et al. Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections. Antimicrobial Agents and Chemotherapy. 2025;69(10). doi:10.1128/aac.01060-24
BibTeX
@article{Turner2025,
author = {Turner, Adrianna M and Kinsella, Paul and Miller, William R and Carter, Glen P and Tran, Truc T and Howden, Benjamin P and Arias, Cesar A},
title = {Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {10},
doi = {10.1128/aac.01060-24}
}
EUVIMED